Nu Skin Enterprises, Inc. (NUS) Stock Competitors & Peer Comparison
See (NUS) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUS | $5.56 | +4.42% | 264.6M | 5.05 | $1.08 | +4.37% |
| PG | $150.21 | +3.52% | 345.9B | 21.72 | $6.84 | +2.87% |
| UL | $59.02 | +5.21% | 124.7B | 19.13 | $3.01 | +3.96% |
| CL | $89.52 | +4.01% | 70.2B | 34.03 | $2.58 | +2.38% |
| KVUE | $18.10 | +3.13% | 34.4B | 21.32 | $0.84 | +4.65% |
| KMB | $101.88 | +4.22% | 33.4B | 19.44 | $5.17 | +5.07% |
| EL | $87.80 | +3.73% | 31.3B | -123.70 | -$0.70 | +1.60% |
| CHD | $98.69 | +3.50% | 23B | 31.92 | $3.04 | +1.25% |
| SGI | $69.62 | +2.67% | 14.9B | 28.39 | $2.50 | +0.90% |
| CLX | $100.27 | +5.36% | 11.9B | 16.01 | $6.15 | +5.05% |
Stock Comparison
NUS vs PG Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, PG has a market cap of 345.9B. Regarding current trading prices, NUS is priced at $5.56, while PG trades at $150.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas PG's P/E ratio is 21.72. In terms of profitability, NUS's ROE is +0.07%, compared to PG's ROE of +0.31%. Regarding short-term risk, NUS is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PG's competition here
NUS vs UL Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, UL has a market cap of 124.7B. Regarding current trading prices, NUS is priced at $5.56, while UL trades at $59.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas UL's P/E ratio is 19.13. In terms of profitability, NUS's ROE is +0.07%, compared to UL's ROE of +0.36%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here
NUS vs CL Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, CL has a market cap of 70.2B. Regarding current trading prices, NUS is priced at $5.56, while CL trades at $89.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas CL's P/E ratio is 34.03. In terms of profitability, NUS's ROE is +0.07%, compared to CL's ROE of +4.75%. Regarding short-term risk, NUS is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CL's competition here
NUS vs KVUE Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, KVUE has a market cap of 34.4B. Regarding current trading prices, NUS is priced at $5.56, while KVUE trades at $18.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas KVUE's P/E ratio is 21.32. In terms of profitability, NUS's ROE is +0.07%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, NUS is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here
NUS vs KMB Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, KMB has a market cap of 33.4B. Regarding current trading prices, NUS is priced at $5.56, while KMB trades at $101.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas KMB's P/E ratio is 19.44. In terms of profitability, NUS's ROE is +0.07%, compared to KMB's ROE of +1.44%. Regarding short-term risk, NUS is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KMB's competition here
NUS vs EL Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, EL has a market cap of 31.3B. Regarding current trading prices, NUS is priced at $5.56, while EL trades at $87.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas EL's P/E ratio is -123.70. In terms of profitability, NUS's ROE is +0.07%, compared to EL's ROE of -0.06%. Regarding short-term risk, NUS is less volatile compared to EL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check EL's competition here
NUS vs CHD Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, CHD has a market cap of 23B. Regarding current trading prices, NUS is priced at $5.56, while CHD trades at $98.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas CHD's P/E ratio is 31.92. In terms of profitability, NUS's ROE is +0.07%, compared to CHD's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CHD's competition here
NUS vs SGI Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, SGI has a market cap of 14.9B. Regarding current trading prices, NUS is priced at $5.56, while SGI trades at $69.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas SGI's P/E ratio is 28.39. In terms of profitability, NUS's ROE is +0.07%, compared to SGI's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SGI's competition here
NUS vs CLX Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, CLX has a market cap of 11.9B. Regarding current trading prices, NUS is priced at $5.56, while CLX trades at $100.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas CLX's P/E ratio is 16.01. In terms of profitability, NUS's ROE is +0.07%, compared to CLX's ROE of +28.26%. Regarding short-term risk, NUS is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CLX's competition here
NUS vs NTCO Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $5.56, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is +0.07%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here
NUS vs ELF Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, ELF has a market cap of 3.3B. Regarding current trading prices, NUS is priced at $5.56, while ELF trades at $60.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas ELF's P/E ratio is 126.57. In terms of profitability, NUS's ROE is +0.07%, compared to ELF's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check ELF's competition here
NUS vs IPAR Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, IPAR has a market cap of 3.1B. Regarding current trading prices, NUS is priced at $5.56, while IPAR trades at $99.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas IPAR's P/E ratio is 18.38. In terms of profitability, NUS's ROE is +0.07%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, NUS is less volatile compared to IPAR. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here
NUS vs SPB Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, NUS is priced at $5.56, while SPB trades at $82.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas SPB's P/E ratio is 16.15. In terms of profitability, NUS's ROE is +0.07%, compared to SPB's ROE of +0.07%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here
NUS vs NWL Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, NWL has a market cap of 1.9B. Regarding current trading prices, NUS is priced at $5.56, while NWL trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas NWL's P/E ratio is -6.58. In terms of profitability, NUS's ROE is +0.07%, compared to NWL's ROE of -0.11%. Regarding short-term risk, NUS is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check NWL's competition here
NUS vs COTY Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, COTY has a market cap of 1.8B. Regarding current trading prices, NUS is priced at $5.56, while COTY trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas COTY's P/E ratio is -3.23. In terms of profitability, NUS's ROE is +0.07%, compared to COTY's ROE of -0.15%. Regarding short-term risk, NUS is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check COTY's competition here
NUS vs EPC Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, EPC has a market cap of 954.3M. Regarding current trading prices, NUS is priced at $5.56, while EPC trades at $21.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas EPC's P/E ratio is -90.04. In terms of profitability, NUS's ROE is +0.07%, compared to EPC's ROE of -0.05%. Regarding short-term risk, NUS is less volatile compared to EPC. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check EPC's competition here
NUS vs HELE Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, HELE has a market cap of 627.3M. Regarding current trading prices, NUS is priced at $5.56, while HELE trades at $28.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas HELE's P/E ratio is -0.69. In terms of profitability, NUS's ROE is +0.07%, compared to HELE's ROE of -0.95%. Regarding short-term risk, NUS is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check HELE's competition here
NUS vs EWCZ Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, NUS is priced at $5.56, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, NUS's ROE is +0.07%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here
NUS vs PTNM Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, NUS is priced at $5.56, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas PTNM's P/E ratio is 346.33. In terms of profitability, NUS's ROE is +0.07%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, NUS is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PTNM's competition here
NUS vs ACU Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, ACU has a market cap of 168.1M. Regarding current trading prices, NUS is priced at $5.56, while ACU trades at $44.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas ACU's P/E ratio is 19.02. In terms of profitability, NUS's ROE is +0.07%, compared to ACU's ROE of +0.08%. Regarding short-term risk, NUS is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check ACU's competition here
NUS vs SLSN Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, SLSN has a market cap of 86.2M. Regarding current trading prices, NUS is priced at $5.56, while SLSN trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas SLSN's P/E ratio is 122.00. In terms of profitability, NUS's ROE is +0.07%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here
NUS vs SKIN Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, SKIN has a market cap of 82.1M. Regarding current trading prices, NUS is priced at $5.56, while SKIN trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas SKIN's P/E ratio is -4.87. In terms of profitability, NUS's ROE is +0.07%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, NUS is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SKIN's competition here
NUS vs GROV Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, GROV has a market cap of 52.1M. Regarding current trading prices, NUS is priced at $5.56, while GROV trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas GROV's P/E ratio is -4.59. In terms of profitability, NUS's ROE is +0.07%, compared to GROV's ROE of -1.06%. Regarding short-term risk, NUS is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check GROV's competition here
NUS vs AXIL Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, AXIL has a market cap of 43.1M. Regarding current trading prices, NUS is priced at $5.56, while AXIL trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas AXIL's P/E ratio is 52.67. In terms of profitability, NUS's ROE is +0.07%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check AXIL's competition here
NUS vs UG Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, UG has a market cap of 32M. Regarding current trading prices, NUS is priced at $5.56, while UG trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas UG's P/E ratio is 13.38. In terms of profitability, NUS's ROE is +0.07%, compared to UG's ROE of +0.21%. Regarding short-term risk, NUS is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UG's competition here
NUS vs MTEX Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, MTEX has a market cap of 11.2M. Regarding current trading prices, NUS is priced at $5.56, while MTEX trades at $5.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas MTEX's P/E ratio is -0.87. In terms of profitability, NUS's ROE is +0.07%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, NUS is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check MTEX's competition here
NUS vs PHH Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, NUS is priced at $5.56, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas PHH's P/E ratio is -0.53. In terms of profitability, NUS's ROE is +0.07%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here
NUS vs RAY Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, RAY has a market cap of 9.2M. Regarding current trading prices, NUS is priced at $5.56, while RAY trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas RAY's P/E ratio is 4.19. In terms of profitability, NUS's ROE is +0.07%, compared to RAY's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check RAY's competition here
NUS vs DSY Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, DSY has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $5.56, while DSY trades at $14.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas DSY's P/E ratio is -0.20. In terms of profitability, NUS's ROE is +0.07%, compared to DSY's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check DSY's competition here
NUS vs BRSH Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $5.56, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is +0.07%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here
NUS vs TANH Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, TANH has a market cap of 2.9M. Regarding current trading prices, NUS is priced at $5.56, while TANH trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas TANH's P/E ratio is -0.03. In terms of profitability, NUS's ROE is +0.07%, compared to TANH's ROE of -0.25%. Regarding short-term risk, NUS is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TANH's competition here
NUS vs TKLF Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, TKLF has a market cap of 842.3K. Regarding current trading prices, NUS is priced at $5.56, while TKLF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas TKLF's P/E ratio is 1.81. In terms of profitability, NUS's ROE is +0.07%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, NUS is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TKLF's competition here
NUS vs DSYWW Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, DSYWW has a market cap of 750.9K. Regarding current trading prices, NUS is priced at $5.56, while DSYWW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas DSYWW's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check DSYWW's competition here
NUS vs BRSHW Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $5.56, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here
NUS vs REV Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $5.56, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is +0.07%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here
NUS vs SUMR Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $5.56, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is +0.07%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here
NUS vs GROV-WT Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, NUS is priced at $5.56, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, NUS is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check GROV-WT's competition here
NUS vs RDEN Comparison June 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 264.6M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, NUS is priced at $5.56, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 5.05, whereas RDEN's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, NUS is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check RDEN's competition here